Dechra Pharmaceuticals PLC — Share Issue/Capital Change 2014

May 30, 2014

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 4477I

Dechra Pharmaceuticals PLC

30 May 2014

30 May 2014

Dechra® Pharmaceuticals PLC

("Dechra" or "the Company") 

In conformity with DTR 5.6.1R, the Company notifies the market of the following:

As at the date of this announcement, the Company's issued share capital consists of 87,708,167 ordinary shares with a nominal value of 1 pence each ("Ordinary Shares"), with voting rights.  The Company does not hold any Ordinary Shares in Treasury.

Therefore, the total number of Ordinary Shares with voting rights is 87,708,167.

The above figure of 87,708,167 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

For further information

Zoe Goulding, Company Secretary            

Telephone number: 01606 814730

About Dechra

Dechra is an international specialist veterinary pharmaceuticals and relates products business.  Its expertise is in the development, manufacturing and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.  For more information please visit: www.dechra.com

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

This information is provided by RNS

The company news service from the London Stock Exchange

END

TVRVBLBXZEFFBBL